SPF50+
OtherSun protection
Other names: Sunscreens
NCT Number: NCT02952235
Use of two high SPF sunscreens under actual use conditions.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
To evaluate the difference in the level of sunburn (erythema) protection following a single period of natural sunlight exposure afforded by application of SPF 50+ and SPF 100+ sunscreens.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Remain outdoors for at least 5 hours on Day 1 during the study with face and neck uncovered (as much as possible)
Exclusion criteria
Sun protection
Other names: Sunscreens
Sun protection
Other names: Sunscreens
Time frame: Day 2
The side-by-side comparison utilized the following condensed two side overall difference scale: L1 = subject's left side noticeably more sunburned than right side, 0= no difference in sunburn, R1= subject's right side noticeably more sunburned than left side. The 0 outcomes were excluded from the analysis.
Time frame: Day 2
Erythema was assessed using a scale of 0 = no burn, 1 = possible burn, not clearly defined; 2 = defined redness clearly caused by UV; 3 = severe sunburn with pronounced redness; and 4 = edema and blisters
Johnson & Johnson Consumer and Personal Products Worldwide
Industry
A Single Center, Randomized, Split-Face, Double-Blinded, Single Sun Exposure Evaluation of Sunscreens of SPF 50+ and Above Under Actual Use Conditions
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02177006
Neoplasms, Neoplasms by Site
Chicago, Illinois, United States
View Trial DetailsNCT03344796
Burns, Erythema
Chicago, Illinois, United States
View Trial DetailsNCT03033654
Sun Protection
View Trial DetailsNCT02376517
Behavior, Children
Chicago, Illinois, United States
View Trial Details